Cartesian Therapeutics
RNAC
#8591
Rank
NZ$0.33 B
Marketcap
NZ$12.75
Share price
0.82%
Change (1 day)
-64.11%
Change (1 year)

Market capitalization of Cartesian Therapeutics (RNAC)

Market cap: NZ$0.33 Billion

As of January 2026 Cartesian Therapeutics has a market cap of NZ$0.33 Billion. This makes Cartesian Therapeutics the world's 8591th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cartesian Therapeutics from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.33 B10.56%
2025NZ$0.29 B-66.37%
2024NZ$0.89 B405.21%
2023NZ$0.17 B-35.19%
2022NZ$0.27 B-53.84%
2021NZ$0.59 B30.01%
2020NZ$0.45 B48.76%
2019NZ$0.30 B242.33%
2018NZ$89.11 M-71.12%
2017NZ$0.30 B-31.49%
2016NZ$0.45 B

End of Day market cap according to different sources

On Jan 19th, 2026 the market cap of Cartesian Therapeutics was reported to be:

NZ$0.33 Billion
by Nasdaq info icon info icon
NZ$0.33 Billion
by CompaniesMarketCap info icon info icon